PharmaEngine and Guangzhou BeBetter Medicine Technology Signed a Collaboration and Research Agreement

Description

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEngine, Inc. (TWO: 4162) announced today the execution of a Collaboration and Research Agreement with Guangzhou BeBetter Medicine Technology Co., Ltd. (BeBetter). The two companies will collaborate to design, synthesize and develop new chemical entities (“drug candidates”) against predefined targets in oncology. This collaboration opens a new chapter for partnership between Taiwan and China in searching for novel anti-cancer drugs. Under the terms of the ag a

Shared by: EON
-
Stats
views:
10
posted:
1/2/2013
language:
Japanese
pages:
2
Document Sample
scope of work template
							
						
About
At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News (More...) delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.
Related docs
Other docs by EON